Digital Diabetes Analytics radically fights diabetes with AI-based analysis of continuous glucose monitoring (CGM) data.
The Swedish startup Digital Diabetes Analytics offers a digital solution (SaaS) for running advanced automatic analysis of continuous glucose data and expert treatment recommendations. The system highlights severe glucose alterations and identifies patients in need of urgent assistance. The decision support tool offers both patient reports and a clinic report.
With the help of the latter, the clinic gets an overview and a tool to prioritize patients based on their needs and the clinic’s resources. The clinic overview helps to create standardized care paths based on the patients’ glucose profiles.
The patient report helps healthcare professionals interpret patients’ individual glucose data. It delivers far more patient information than just looking at the patient’s glucose values over a 24-hours interval.
Soon, the company will launch OneTwoDiabetes. This is an app for people living with type 1 and type 2 diabetes. The application includes a multi-dimensional analysis with six primary analyses: Time in Range, Hyper, Hypo, Variability, Meals, and Basal Pressure. OneTwo provides feedback on treatments, emphasizing successful strategies and suggestions for improvements to understand why blood sugar fluctuates.
So why did we invest in Digital Diabetes Analytics? Despite rapid growth in CGM/device usage, healthcare professionals are overwhelmed by data and its impact on clinical outcomes remains limited. The startup changes this with its AI-based decision support tool for patient prioritization and treatment, plus an app interface for patient empowerment, improving patient management by turning data into improved quality of life and reducing costs for healthcare providers.
And let’s not forget that diabetes is the fastest growing chronic disease: From 108m people with diabetes in 1980 to 537m now — one in every ten adults — to 783m by 2045, a 46% increase from today.
